amitriptyline has been researched along with Diabetes Mellitus, Gestational in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Wang, XY | 1 |
Ying, XH | 1 |
Jiang, HY | 1 |
Dandjinou, M | 1 |
Sheehy, O | 1 |
BĂ©rard, A | 1 |
1 review available for amitriptyline and Diabetes Mellitus, Gestational
Article | Year |
---|---|
Antidepressant use during pregnancy and the risk for gestational diabetes: a systematic review and meta-analysis.
Topics: Amitriptyline; Antidepressive Agents; Diabetes, Gestational; Female; Humans; Pregnancy; Selective Se | 2023 |
1 other study available for amitriptyline and Diabetes Mellitus, Gestational
Article | Year |
---|---|
Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Case-Control Studies; Cohort Studies; Depre | 2019 |